TTD | Drug: D0T8LY

Drug General Information
Drug ID	D0T8LY
Former ID	DNC004080
Drug Name	PYRIDINE
Drug Type	Small molecular drug
Indication	Discovery agent		Phase 4	[524763]
Structure		Download 2D MOL 3D MOL
Formula	C5H5N
Canonical SMILES	CN1CCCC1C2=CN=CC=C2.C(C(C(=O)O)O)(C(=O)O)O
InChI	1S/C10H14N2.C4H6O6/c1-12-7-3-5-10(12)9-4-2-6-11-8-9;5-1(3(7)8)2(6)4(9)10/h2,4,6,8,10H,3,5,7H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)
InChIKey	QLDPCHZQQIASHX-UHFFFAOYSA-N
PubChem Compound ID	1049
Target and Pathway
Target(s)	Thromboxane-A synthase	Target Info	Inhibitor	[533575]
BioCyc Pathway	C20 prostanoid biosynthesis
KEGG Pathway	Arachidonic acid metabolism
	Metabolic pathways
	Platelet activation
PathWhiz Pathway	Arachidonic Acid Metabolism
WikiPathways	Prostaglandin Synthesis and Regulation
	Arachidonic acid metabolism
	Phase 1 - Functionalization of compounds
	Eicosanoid Synthesis
References
Ref 524763	ClinicalTrials.gov (NCT02143167) Resistance Training and Amino Pyridine in Multiple Sclerosis. U.S. National Institutes of Health.
Ref 533575	J Med Chem. 1981 Oct;24(10):1149-55.Highly selective inhibitors of thromboxane synthetase. 2. Pyridine derivatives.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information